Nanoparticles based drug delivery system: Recent development in treatment of some chronic diseases

Authors

  • Mona K Galal Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.
  • Samira H. Aljuaydi Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.
  • Maha M. Rashad Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.

Keywords:

Nanoparticles, Drug delivery system, Cancer, Alzheimer, Diabetes

Abstract

In recent years nanotechnology has proven that nanoparticles acquire a great development in medical applications. Its combination with therapeutic drugs overcomes the limitations of free therapeutics. Further, these systems can deliver drug to specific tissues and provide controlled release therapy. This targeted and sustained drug delivery decreases the drug related toxicity and increases patient’s compliance with less frequent dosing. Recently, there are several outstanding applications of nanomedicine in the treatment of various chronic diseases. The current review presents an updated summary of recent advances in the field of nanomedicines and nano-based drug delivery systems. This article emphasize the type of clinically used nanoparticles as well as their current delivery strategies for specific diseases such as cancer, Alzheimer, diabetes Meletus and osteoarthritis.

Downloads

Published

2026-01-01

How to Cite

Mona K Galal, Aljuaydi, S. H., & Rashad, M. M. (2026). Nanoparticles based drug delivery system: Recent development in treatment of some chronic diseases. Journal of Advanced Veterinary Research, 16(2), 313-318. Retrieved from https://advetresearch.com/index.php/AVR/article/view/2460

Issue

Vol. 16 No. 2 (2026): January

Section

Review Article

License

Copyright (c) 2026 Journal of Advanced Veterinary Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).

For more information: 

Attribution-NonCommercial-NoDerivs 
CC BY-NC-ND

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license

Most read articles by the same author(s)